{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:30:52Z","timestamp":1759624252627,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5028,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.exphem.2008.04.004","type":"journal-article","created":{"date-parts":[[2008,6,12]],"date-time":"2008-06-12T09:55:45Z","timestamp":1213264545000},"page":"1205-1215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Erythroid-lineage\u2013specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation"],"prefix":"10.1016","volume":"36","author":[{"given":"Paul M.","family":"Armistead","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn","family":"Gerwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Iravani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahram","family":"Chahardouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrbano","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wandi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Neuberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ardeshir","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2008.04.004_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","article-title":"Beta-thalassemia","volume":"353","author":"Rund","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib2","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib3","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/asheducation-2006.1.398","article-title":"Reduced-intensity regimens in allogeneic hematopoietic stem cell transplantation for hemoglobinopathies","author":"Locatelli","year":"2006","journal-title":"Hematol Am Soc Hematol Educ Prog"},{"key":"10.1016\/j.exphem.2008.04.004_bib4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood.V93.4.1164","article-title":"Bone marrow transplantation in adult thalassemic patients","volume":"93","author":"Lucarelli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib5","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1701291","article-title":"Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium","volume":"22","author":"Vermylen","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib8","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2141.2007.06592.x","article-title":"Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research","volume":"137","author":"Panepinto","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2008.04.004_bib9","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1182\/blood-2005-04-1376","article-title":"Evidence for ineffective erythropoiesis in severe sickle cell disease","volume":"106","author":"Wu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1182\/blood-2002-05-1365","article-title":"A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation","volume":"101","author":"Hochberg","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib11","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.exphem.2008.04.004_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0301-472X(03)00227-3","article-title":"Molecular assessment of erythroid lineage chimerism following non-myeloablative allogeneic stem cell transplantation","volume":"31","author":"Wu","year":"2003","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2008.04.004_bib13","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ajh.21002","article-title":"Reduced intensity stem cell transplantation for treatment of class 3 Lucarelli severe thalassemia patients","volume":"82","author":"Hongeng","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2008.04.004_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bmt.1705685","article-title":"Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients","volume":"40","author":"Iravani","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(04)16628-2","article-title":"Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children","volume":"364","author":"Jacobsohn","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.exphem.2008.04.004_bib16","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1182\/blood.V87.5.2082.2082","article-title":"Marrow transplantation for patients with thalassemia: results in class 3 patients","volume":"87","author":"Lucarelli","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<281::AID-AJH7>3.0.CO;2-O","article-title":"Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats","volume":"52","author":"Frankel","year":"1996","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2008.04.004_bib18","first-page":"43","article-title":"DNA typing for bone marrow engraftment follow-up after allogeneic transplant: a comparative study of current technologies","volume":"16","author":"Leclair","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib19","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/blood.V96.7.2606","article-title":"A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia","volume":"96","author":"Pootrakul","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib20","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1182\/blood.V87.8.3494.bloodjournal8783494","article-title":"Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia","volume":"87","author":"Andreani","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib21","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1053\/bbmt.2001.v7.pm11787529","article-title":"Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia","volume":"7","author":"Walters","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nm0797-783","article-title":"Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning","volume":"3","author":"Sykes","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib23","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1182\/blood-2003-03-0712","article-title":"Chimerism and cure: hematologic and pathologic correction of murine sickle cell disease","volume":"102","author":"Kean","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","article-title":"Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia","volume":"9","author":"Iannone","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440119","article-title":"Bone marrow transplantation without myeloablation for sickle cell disease","volume":"344","author":"Krishnamurti","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-472X(01)00775-5","article-title":"Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease","volume":"30","author":"Schleuning","year":"2002","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2008.04.004_bib27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/MPH.0b013e31802d3e53","article-title":"Transplantation of a child with sickle cell anemia with an unrelated cord blood unit after reduced intensity conditioning","volume":"28","author":"Mazur","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.exphem.2008.04.004_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/sj.bmt.1704795","article-title":"A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders","volume":"35","author":"Shenoy","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib29","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.bmt.1704745","article-title":"Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin","volume":"35","author":"Horan","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1702518","article-title":"Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease","volume":"26","author":"van Besien","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bmt.1702242","article-title":"Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-non-identical sibling or parent transplants","volume":"25","author":"Gaziev","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib32","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1182\/blood.V95.10.3262","article-title":"Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation","volume":"95","author":"Georges","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib33","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/bbmt.2001.v7.pm11669214","volume":"7","author":"Antin","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1703668","article-title":"Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia","volume":"30","author":"Maschan","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2008.04.004_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10245330601111540","article-title":"Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Zhu","year":"2007","journal-title":"Hematology"},{"key":"10.1016\/j.exphem.2008.04.004_bib36","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood-2004-08-3032","article-title":"Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ","volume":"105","author":"Anderson","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib37","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2008.04.004_bib38","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm1038","article-title":"Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease","volume":"10","author":"Merad","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.exphem.2008.04.004_bib39","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08001756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X08001756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:26:06Z","timestamp":1759566366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X08001756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0301472X08001756"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2008.04.004","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythroid-lineage\u2013specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2008.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}